Correlation Between Bellicum Pharmaceuticals and Lixte Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bellicum Pharmaceuticals and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellicum Pharmaceuticals and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bellicum Pharmaceuticals and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Bellicum Pharmaceuticals and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellicum Pharmaceuticals with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellicum Pharmaceuticals and Lixte Biotechnology.

Diversification Opportunities for Bellicum Pharmaceuticals and Lixte Biotechnology

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bellicum and Lixte is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bellicum Pharmaceuticals and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Bellicum Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellicum Pharmaceuticals are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Bellicum Pharmaceuticals i.e., Bellicum Pharmaceuticals and Lixte Biotechnology go up and down completely randomly.

Pair Corralation between Bellicum Pharmaceuticals and Lixte Biotechnology

If you would invest  222.00  in Lixte Biotechnology Holdings on November 2, 2024 and sell it today you would earn a total of  26.00  from holding Lixte Biotechnology Holdings or generate 11.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy5.26%
ValuesDaily Returns

Bellicum Pharmaceuticals  vs.  Lixte Biotechnology Holdings

 Performance 
       Timeline  
Bellicum Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bellicum Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Bellicum Pharmaceuticals is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Lixte Biotechnology 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lixte Biotechnology Holdings are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Lixte Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bellicum Pharmaceuticals and Lixte Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bellicum Pharmaceuticals and Lixte Biotechnology

The main advantage of trading using opposite Bellicum Pharmaceuticals and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellicum Pharmaceuticals position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.
The idea behind Bellicum Pharmaceuticals and Lixte Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device